Publications by authors named "Y Adar"

Claim this Profile
D
Development and Validation of a Plaque Assay to Determine the Titer of a Recombinant Live-Attenuated Viral Vaccine for SARS-CoV-2.
Einat Toister, Lilach Cherry, Edith Lupu, Arik Monash, Eyal Dor, Yaakov Adar

Vaccines (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced production yields of rVSV-SARS-CoV-2 vaccine using Fibra-Cel macrocarriers.
Noam Cohen, Irit Simon, Ophir Hazan, Arnon Tal, Hanan Tzadok, Yaakov Adar

Front Bioeng Biotechnol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic and Protective Properties of Subunit- vs. Whole Toxoid-Derived Anti-Botulinum Equine Antitoxin.
Alon Ben David, Ada Barnea, Amram Torgeman, Eran Diamant, Eyal Dor, Yaakov Adar

Vaccines (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.
Arik Makovitzki, Elad Lerer, Yaron Kafri, Yaakov Adar, Lilach Cherry

Vaccine· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through Chromatography.
Elad Lerer, Ziv Oren, Yaron Kafri, Yaakov Adar, Einat Toister

BioTech (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis